Comprehensive pre-operative preparation substantially impacts surgical outcomes, complication rates, and patient safety. Thorough medical history review, physical examination, necessary laboratory testing, and medication optimization enable clinicians to identify medical contraindications, assess surgical risk using validated classification systems, and implement modifications reducing perioperative complications. Evidence demonstrates that systematic pre-operative assessment protocols identifying previously unknown medical conditions prevent adverse events, while appropriate medication management (particularly anticoagulation) and optimized patient health status enable safe surgical completion.

Medical History Review and Assessment

Comprehensive medical history must include complete cardiovascular assessment (prior heart attacks, heart failure, arrhythmias, hypertension, current medications), respiratory disease (asthma, COPD, sleep apnea), hematologic conditions (bleeding disorders, anticoagulant/antiplatelet use), endocrine disease (diabetes, thyroid dysfunction, adrenal insufficiency), hepatic disease, and renal disease. Recent surgical procedures or anesthesia complications should be documented, as prior adverse reactions predict increased complication risk.

ASA (American Society of Anesthesiologists) physical status classification enables standardized surgical risk assessment. ASA I patients (healthy, no systemic disease) carry minimal surgical risk. ASA II patients (mild systemic disease, well-controlled) carry low risk. ASA III patients (moderate systemic disease, significant functional limitation) carry moderate risk. ASA IV patients (severe systemic disease, life-threatening) carry high risk; elective surgery should generally be deferred until optimization occurs. ASA V (moribund patient) represents absolute contraindication to elective surgery.

Physical examination assesses vital signs (blood pressure, heart rate, respiratory rate, oxygen saturation, temperature), airway anatomy (jaw opening, neck mobility, airway visualization), and general patient appearance (alertness, skin perfusion, obvious distress). Hypertension (≥160/100 mmHg) warrants postponement of elective surgery until optimization; acutely elevated blood pressure significantly increases perioperative complication risk. Tachycardia (heart rate >100 bpm) or hypoxemia (oxygen saturation <94%) warrant investigation for underlying conditions before proceeding with elective surgery.

Medication Reconciliation

Complete medication list including over-the-counter medications, supplements, and herbal products must be documented. Herbal products including ginkgo biloba, ginger, and garlic possess anticoagulant properties potentially increasing bleeding risk; these should ideally be discontinued 1-2 weeks pre-operatively. Nonsteroidal anti-inflammatory drugs (NSAIDs) impair hemostasis; chronic users may benefit from discontinuation 1-2 weeks pre-operatively if surgical hemostasis difficulty is anticipated.

Systemic corticosteroid use (chronic or recent) impacts surgical stress response and infection risk. Patients on chronic corticosteroid therapy require perioperative corticosteroid supplementation (stress-dose coverage) as endogenous adrenal response becomes suppressed. Typical supplementation includes additional dexamethasone dose peri-operatively; dose varies by patient status and baseline corticosteroid dose. Coordination with prescribing physician guides appropriate supplementation.

Anticoagulation Management

Warfarin management requires pre-operative INR (international normalized ratio) assessment within 72 hours of surgery. INR range of 2.0-3.5 considered target therapeutic range for most indications. For minor dental surgery (simple extraction, implant placement), standard local hemostasis techniques (gauze pressure, bone wax, hemostatic agents) control bleeding adequately without warfarin discontinuation. Continuing warfarin while employing enhanced hemostasis proves superior to warfarin discontinuation, which risks thrombotic complications exceeding hemorrhagic risk.

For major surgery (extensive bone removal, multiple extractions, flap elevation), warfarin discontinuation 3-5 days pre-operatively reduces INR to <2.5 target level. Bridging anticoagulation with unfractionated heparin (if high thrombotic risk) may be considered; however, for most patients, brief warfarin discontinuation without bridging proves acceptable for procedures lasting <1 hour.

INR assessment immediately pre-operatively (within 24 hours) confirms appropriate therapeutic status before proceeding. Excessive elevation (INR >4) warrants postponement and prescriber contact for warfarin adjustment. Coordination with prescribing physician (cardiologist, internist) ensures appropriate management aligned with patient's underlying condition.

Direct oral anticoagulants (DOACs: apixaban, dabigatran, edoxaban, rivaroxaban) require different management compared to warfarin. Most minor dental procedures can proceed without DOAC discontinuation, with standard local hemostasis. Prescriber consultation remains appropriate for procedures exceeding 60 minutes or involving extensive bone removal. Unlike warfarin, INR monitoring is impossible; perioperative assessment of bleeding risk guides DOAC continuation decisions.

Aspirin monotherapy continuation for minor dental procedures remains standard, as aspirin alone rarely produces excessive post-operative bleeding with appropriate hemostasis. Dual antiplatelet therapy (aspirin plus clopidogrel or other P2Y12 inhibitor) carries substantially increased bleeding risk; prescriber consultation strongly recommended before interruption, as premature cessation risks acute stent thrombosis in patients with recent coronary stents.

Diabetes Management

Pre-operative fasting glucose target of <200 mg/dL, with HbA1c <8% (if available), indicates reasonable metabolic control for elective surgery. Patients with HbA1c >8% or pre-operative glucose >250 mg/dL demonstrate impaired wound healing and infection risk; non-urgent surgery postponement until metabolic optimization proves prudent.

NPO (nothing by mouth) instructions for sedated or general anesthesia procedures require modification for diabetic patients. Morning fasting blood glucose assessment determines peri-operative glucose management. Non-insulin diabetics may skip morning medications; insulin-dependent diabetics may take 50% of usual morning insulin dose prior to fasting. Glucose monitoring during surgery (finger-stick assessment each 30-60 minutes) guides supplemental insulin dosing if hyperglycemia develops.

Post-operative glucose monitoring continues as dietary resumption occurs. Stress hyperglycemia is expected post-operatively; insulin supplementation may be necessary even in non-insulin-dependent patients until stress phase resolves. Coordination with prescribing physician regarding peri-operative glucose management optimizes metabolic control.

Bisphosphonate Assessment

Current AAOMS (American Association of Oral and Maxillofacial Surgeons) position paper stratifies medication-related osteonecrosis of the jaw (MRONJ) risk by drug type, route of administration, duration of therapy, and presence of additional risk factors. Intravenous bisphosphonates (for malignancy or high-dose osteoporosis) carry substantially higher MRONJ risk compared to oral bisphosphonates. Risk stratification guides surgical approach decisions: low-risk patients proceed with standard surgical protocols; high-risk patients warrant enhanced infection prevention and surgical minimalism (avoid extensive flap elevation, minimize alveolar bone removal when possible).

Treatment duration threshold (3+ years) increases MRONJ risk; patients on bisphosphonates <3 years show substantially lower risk. Dental extractions in high-risk patients warrant specialized management: limited flap elevation, minimal bone removal, careful closure, post-operative chlorhexidine rinse protocol, and patient education regarding continued risk of MRONJ years after extraction.

Pre-operative Imaging

Cone beam computed tomography (CBCT) assessment of impacted teeth identifies anatomic relationship to inferior alveolar nerve (IAN), confirming proximity to nerve requiring surgical care. Mandibular third molar CBCT assessment detecting IAN darkening or interruption by tooth root warrants special surgical care to minimize paresthesia risk. CBCT also identifies proximity to maxillary sinus for maxillary impactions.

Radiographic assessment (periapical or panoramic films) of extractable teeth identifies root morphology, presence of retained root tips, or anatomic anomalies affecting extraction difficulty. Multi-rooted teeth require extraction planning incorporating root removal strategy (sectioning, separate removal, etc.).

Standard chest radiographs or cardiac imaging rarely necessary for routine dental surgery unless ASA IV status or recent cardiovascular event suggests need. Judgment regarding specialized imaging depends on specific medical history and planned procedure scope.

Anxiety Management Planning

Pre-operative anxiety assessment using anxiety rating scales (0-10 anxiety level) identifies patients requiring anxiety management strategies. High-anxiety patients (≥7/10) benefit from pre-medication (oral anxiolytic prior to appointment), supportive environment optimization (familiar staff, quiet setting, controlled lighting), and explicit time allowance for relaxation before beginning procedure.

Oral benzodiazepines (triazolam 0.25-0.5mg 30 minutes pre-operatively, diazepam 2-5mg 30 minutes pre-operatively) produce sedation without consciousness loss, reducing anxiety and improving cooperation. Timing to achieve peak sedation 30-45 minutes post-administration enables optimal effect during procedure. Post-operative monitoring ensures adequate dissipation before patient discharge.

Patients with severe anxiety or specific phobias may benefit from referral to anxiolytic sedation specialists for parenteral sedation (nitrous oxide, midazolam) enabling greater anxiety reduction with provider-supervised safety monitoring.

NPO (fasting) protocols for sedated or general anesthesia procedures prevent aspiration risk. Typical NPO guidelines include no solids 6+ hours, no clear liquids 2 hours pre-operatively. Patients should be explicitly instructed to withhold morning medications unless specifically discussed; exceptions include critical medications (anti-hypertensives, beta-blockers, cardiac medications) that may require specific peri-operative timing.

Transportation arrangements must be confirmed, particularly for sedated procedures where patient should not operate vehicles. Written transportation instructions ensure patient has arranged appropriate ride home and understands impairment duration.

Comprehensive informed consent process documents risks (bleeding, infection, nerve injury, swelling, temporary numbness, dry socket/alveolar osteitis), benefits (infection prevention through extraction, space creation, treatment completion), and alternatives to planned procedure. Discussion of specific anatomic risks (nerve proximity, sinus involvement) enables informed decision-making. Documentation of informed consent in patient record proves essential for medicolegal protection and demonstrates appropriate patient counseling.

Companion presence during consent discussion improves information retention and enables family involvement in decision-making. Written consent forms supplementing verbal discussion ensure documented comprehension and agreement.

Pre-operative Checklist

Systematic checklist implementation prevents important preparation steps from being overlooked. Critical checklist elements include: medical history review and ASA classification completed, vital signs documented, medication reconciliation completed, laboratory values (INR, glucose) obtained if indicated, imaging reviewed and available, NPO status confirmed, anxiety management plan established, informed consent documented, and emergency contact information documented.

Procedural checklist ensures sterile field establishment, appropriate instrument setup, emergency medications availability (epinephrine, reversal agents), and monitoring equipment functionality.

Summary

Comprehensive pre-operative preparation significantly reduces surgical complications and improves patient outcomes. Medical history review combined with ASA physical status classification enables standardized surgical risk assessment. Anticoagulation management requires individualized approach based on medication type and surgical scope: minor procedures proceed with warfarin continuation if INR adequately controlled; major procedures require coordination with prescribing physician regarding modification. Diabetes management emphasizes pre-operative glucose optimization and peri-operative glucose monitoring. Bisphosphonate assessment risk-stratifies MRONJ complication risk, guiding surgical approach modification for high-risk patients. Pre-operative imaging identifies anatomic complexities affecting surgical approach. Anxiety management planning addresses pre-operative anxiety through anxiolytic medications and supportive environment optimization. Comprehensive informed consent documenting risks, benefits, and alternatives ensures appropriate patient autonomy and medicolegal protection. Systematic checklist utilization ensures critical preparation steps completion. Clinicians implementing evidence-based pre-operative protocols deliver safe surgery with optimized outcomes and minimized perioperative complications.